Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,695 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Memory plays a critical role in AI growth, and micron's data center gross margin has surged to industry-leading level...
Axiom Space has closed a $350 million round to accelerate its private space station project. This milestone highlight...
Quantum computing is moving from theory to real-world use. In this guide, we break down the three best quantum comput...
Unisys (UIS) 2026 earnings could hinge on services growth, margin discipline, and backlog strength. This guide breaks...
This in-depth look breaks down Unity's Q1 2026 earnings call, outlining revenue drivers, profitability, and what the ...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
Andrej Karpathy, a founding member of OpenAI, has moved to Anthropic, marking a pivotal leadership shift in the AI ra...
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
Ooma stock is catching the eye of traders and long-term investors alike. Here's a clear look at the drivers, the numb...
Two travel giants—Vail Resorts and Viking Holdings—represent different bets on leisure demand. This analysis compares...
As AI use expands from training to real-world deployment, memory players like Micron face a pivotal moment. This arti...